Definitive Healthcare (DH) Stock Forecast & Price Target

$4.29 -0.17 (-3.81%)

(As of 11/15/2024 ET)

Definitive Healthcare - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
1

Hold
7

Buy
3

Based on 11 Wall Street analysts who have issued ratings for Definitive Healthcare in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 7 have given a hold rating, and 3 have given a buy rating for DH.

Consensus Price Target

$5.81
35.49% Upside

According to the 11 analysts' twelve-month price targets for Definitive Healthcare, the average price target is $5.81. The highest price target for DH is $8.00, while the lowest price target for DH is $4.00. The average price target represents a forecasted upside of 35.49% from the current price of $4.29.

DH Analyst Ratings Over Time

Type	Current Forecast 11/16/23 to 11/15/24	1 Month Ago 10/17/23 to 10/16/24	3 Months Ago 8/18/23 to 8/17/24	1 Year Ago 11/16/22 to 11/16/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	3 Buy rating(s)	3 Buy rating(s)	2 Buy rating(s)	4 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	7 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$5.81	$5.81	$5.64	$11.94
Forecasted Upside	35.49% Upside	28.03% Upside	40.37% Upside	49.59% Upside
Consensus Rating	Hold	Hold	Hold	Moderate Buy

This Bull Market Indicator called NVDA at $116 (Ad)

Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…

All you have to do is follow this link here

DH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

DH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Definitive Healthcare Stock vs. The Competition

Type	Definitive Healthcare	Medical Companies	S&P 500
Consensus Rating Score	2.18	2.80	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	35.49% Upside	28,527.22% Upside	9.92% Upside
News Sentiment Rating	Neutral News See Recent DH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
11/8/2024	Needham & Company LLC 2 of 5 stars		Reiterated Rating	Hold
9/17/2024	BTIG Research 2 of 5 stars	D. Larsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$7.00	+57.66%
8/9/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Lower Target	Hold ➝ Hold	$7.00 ➝ $5.00	+27.23%
8/7/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$6.00 ➝ $5.00	+32.63%
8/7/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$6.00 ➝ $4.00	+6.10%
8/6/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$9.00 ➝ $5.00	+36.99%
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
7/31/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$9.50 ➝ $7.50	+128.66%
7/31/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Neutral ➝ Underweight	$7.00 ➝ $5.00	-12.89%
5/14/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform
5/8/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$10.00 ➝ $8.00	+58.42%
8/16/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$17.00 ➝ $10.50	+3.65%
8/15/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$12.00 ➝ $10.50	+0.19%
2/24/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$19.00 ➝ $15.00	+26.16%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 08:41 PM ET.

DH Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Definitive Healthcare is $5.81, with a high forecast of $8.00 and a low forecast of $4.00.
: 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There is currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DH, but not buy additional shares or sell existing shares.
: According to analysts, Definitive Healthcare's stock has a predicted upside of 35.49% based on their 12-month stock forecasts.
: Definitive Healthcare has been rated by research analysts at BTIG Research, and Needham & Company LLC in the past 90 days.
: Analysts like Definitive Healthcare less than other "medical" companies. The consensus rating for Definitive Healthcare is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how DH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

My Top Trump Rally Stocks (Ad)

This Catalyst Hits Once Every 4 Years.. Every four years, on the day of the election, a catalyst is triggered. Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%... within 90 days. And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.

Click here for details on your FREE RSVP.

This page (NASDAQ:DH) was last updated on 11/15/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Definitive Healthcare (DH) Stock Forecast & Price Target